Joonho Choi

Joonho Choi

Auto-generated profile, based on publicly available information

Joonho Choi

Department of Psychiatry, Hanyang University Guri Hospital, Guri, Republic of Korea

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2020 in Clinical Psychopharmacology and Neuroscience
Verified
Journal Article
Open access
PDF file
JLJung Suk Lee
Jung Suk Lee
JYJe-Yeon Yun
Je-Yeon Yun
SKShi Hyun Kang
Shi Hyun Kang
SLSeung Jae Lee
Seung Jae Lee
JCJoon-Ho Choi
Joon-Ho Choi
CKChan-Hyung Kim
Chan-Hyung Kim
Jung Suk Lee, Je-Yeon Yun, Shi Hyun Kang, Seung Jae Lee, Joon-Ho Choi, Beomwoo Nam, Seung-Hwan Lee, Young-Chul Chung, Chan-Hyung Kim. Clin Psychopharmacol Neurosci 2020;18:386-94. https://doi.org/10.9758/cpn.2020.18.3.386

1 September 2014 in Journal of Affective Disorders
Verified
Journal Article
Closed access
Seon-Cheol ParkSeon-Cheol Park
Seon-Cheol Park
JCJoonho Choi
Joonho Choi
JKJae-Min Kim
Jae-Min Kim
TJTae-Youn Jun
Tae-Youn Jun
MLMin-Soo Lee
Min-Soo Lee
Seon-Cheol ParkSeon-Cheol Park
Seon-Cheol Park

1 January 2015 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
Seon-Cheol ParkSeon-Cheol Park
Seon-Cheol Park
HLHwa-Young Lee
Hwa-Young Lee
DLDong-Woo Lee
Dong-Woo Lee
SHSang-Woo Hahn
Sang-Woo Hahn
SPSang-Ho Park
Sang-Ho Park
YKYoung-Joon Kwon
Young-Joon Kwon
Park SC, et al. J Korean Med Sci. 2015 Jul;30(7):953-959. https://doi.org/10.3346/jkms.2015.30.7.953

Verified
Journal Article
Open access
PDF file
Yong-Ku KimYong-Ku Kim
Yong-Ku Kim
JCJoonho Choi
Joonho Choi
Seon-Cheol ParkSeon-Cheol Park
Seon-Cheol Park
Despite the substantial burden of illness in schizophrenia, there has been a discrepancy between the beneficial effects of an increased use of antipsychotic medications and achieving limited recovery or remission. Because the focus of the most common antipsychotic medications is on dopamine, which is associated with positive symptoms, there is an unmet need for patients with negative symptoms. Since cognitive and negative symptoms rather than positive symptoms are more closely associated with psychosocial impairments in patients with schizophrenia, the non-dopaminergic systems including glutamate and γ-aminobutyric acid (GABA) of the prefrontal cortex should be of concern as well. The balance of excitation and inhibition has been associated with epigenetic modifications and thus can be analyzed in terms of a neurodevelopmental and neural circuitry perspective. Hence, a novel bio-psychosocial-behavioral model for the treatment of schizophrenia is needed to account for the non-dopaminergic systems involved in schizophrenia, rather than dopaminergic mechanisms. This model can be understood from the viewpoint of neurodevelopment and neural circuitry and should include the staging care, personalized care, preventive care, reducing the cognitive deficits, and reducing stigma. Thomas R. Insel proposed this as a goal for schizophrenia treatment to be achieved by 2030.

1 January 2014 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
EWEunsoo Won
Eunsoo Won
Seon-Cheol ParkSeon-Cheol Park
Seon-Cheol Park
KHKyu-Man Han
Kyu-Man Han
SSSeung-Hwan Sung
Seung-Hwan Sung
HLHwa-Young Lee
Hwa-Young Lee
YPYong-Chon Park
Yong-Chon Park
Won E, et al. J Korean Med Sci. 2014 Apr;29(4):468-484. https://doi.org/10.3346/jkms.2014.29.4.468

1 March 2015 in Journal of Affective Disorders
Verified
Journal Article
Closed access
Seon-Cheol ParkSeon-Cheol Park
Seon-Cheol Park
SØSøren Dinesen Østergaard
Søren Dinesen Østergaard
JCJoonho Choi
Joonho Choi
JKJae-Min Kim
Jae-Min Kim
TJTae-Youn Jun
Tae-Youn Jun
Seon-Cheol ParkSeon-Cheol Park
Seon-Cheol Park